Categories
Press Release

Intravenous Immunoglobulin Market To Exhibit 6.2% CAGR, Fortune Business Insights Says Rising Cases Of Immunodeficiency Disorders To Drive Market

The global intravenous immunoglobulin market is likely to witness considerable growth driven by recent molecular advancements. According to a report published by Fortune Business Insights, titled “Intravenous Immunoglobulin Industry Size, Share & Industry Analysis By Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Regional Forecast, 2018 – 2025,” the was valued at USD 9,787.6 Million in 2017 and is projected to reach USD 15,789.1 Million by 2025 exhibiting a CAGR of 6.2% in the forecast period (2018-2025).

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593

Some of the leading companies that are operating in the market are:

  • Shire (Takeda Pharmaceutical Company Limited)
  • CSL Behring
  • Grifols, S.A.
  • Kedrion S.p.A
  • Octapharma
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products Holdings, Inc.
  • LFB SA
  • Shanghai RAAS Blood Products Co., Ltd.

Increasing Adoption of Immunoglobulins to Help Asia Pacific Register Fastest Growth

According to the report, The Global Intravenous Immunoglobulin Industry was dominated by North America with a market value of US$ 5,587.4 Mn in 2017. The region is likley to remain dominant through the forecast period as well due to the presence of first line treatment for critical immune disorders. Other factors boosting the market in the region are rising number of patients and efficient results of the intravenous immunoglobulin treatment.

On the other side, the market in Asia Pacific is anticipated to grpow at faster rate in the coming years on account of the rise in awareness about the treatment option avaiulable for immunologic deficiencies. In addition to this, the rise in adoption and expenditure of immunoglobulins in economies such as Japan, China,and Indiais anticipated to boost the market in the region.

Key Segmentation:

By Indication

  • Primary Immunodeficiency
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Guillain-Barré Syndrome (GBS)
  • Immune Thrombocytopenic Purpura (ITP)
  • Multifocal Motor Neuropathy (MMN)
  • Others

By Form

  • Liquid
  • Lyophilized

By End User

  • Hospitals
  • Clinics
  • Homecare

By Geography

  • North America (the U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America
  • Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)

Some major points from Table of Content:

  1. Introduction

1.1.  Research Scope

1.2.  Market Segmentation

1.3.  Research Methodology

1.4.  Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1.  Market Drivers

3.2.  Market Restraints

3.3.  Market Opportunities

  1. Key Insights

4.1.  Pipeline Analysis

4.2.  Overview of Regulatory Scenario by Key Regions

4.3.  Key Industry Developments

4.4.  Number (Estimated) of Primary Immunodeficiency (PI) Patients by Key Countries

4.5.  Overview of Reimbursement Scenario

  1. Global Intravenous Immunoglobulin Industry Analysis, Insights and Forecast, 2015-2025

5.1.  Key Findings /Summary

5.2.  Market Analysis, Insights and Forecast – By Indication

5.2.1.     Primary Immunodeficiency

5.2.2.     Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

5.2.3.     Guillain-Barré Syndrome (GBS)

5.2.4.     Immune Thrombocytopenic Purpura (ITP)

5.2.5.     Multifocal Motor Neuropathy (MMN)

5.2.6.     Others

5.3.  Market Analysis, Insights and Forecast – By Form

5.3.1.     Liquid

5.3.2.     Lyophilized

5.4.  Market Analysis, Insights and Forecast – By End User

5.4.1.     Hospitals

5.4.2.     Clinics

5.4.3.     Homecare

5.5.  Market Analysis, Insights and Forecast – By Region

5.5.1.     North America

5.5.2.     Europe

5.5.3.     Asia Pacific

5.5.4.     Latin America

5.5.5.     Middle East & Africa

  1. North America Market Analysis,Insights and Forecast, 2015-2026

6.1.  Key Findings / Summary

6.2.  Market Analysis – By Indication

6.2.1.     Primary Immunodeficiency

6.2.2.     Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

6.2.3.     Guillain-Barré Syndrome (GBS)

6.2.4.     Immune Thrombocytopenic Purpura (ITP)

6.2.5.     Multifocal Motor Neuropathy (MMN)

6.2.6.     Others

6.3.  Market Analysis – By Form

6.3.1.     Liquid

6.3.2.     Lyophilized

6.4.  Market Analysis – By End User

6.4.1.     Hospitals

6.4.2.     Clinics

6.4.3.     Homecare

6.5.  Market Analysis – By Country

6.5.1.     U.S.

6.5.2.     Canada

More Trending Topics From Fortune Business [email protected] 

Global Peritoneal Dialysis Market Size, Share & Growth 2025

Dental Implants Market Size, Share & Growth Analysis 2026

Genomics Market Size, Growth, Trends | Analysis Report, 2026

About us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]
Fortune Business Insights™
Linkedin | Twitter | Blogs

Categories
Press Release

Intravenous Immunoglobulin Market is Expected to Rise at 6.2% CAGR from 2018-2025; Increasing Regulatory Approvals Will Aid Market Growth, says Fortune Business Insights

Fortune Business Insights predicts the Global Intravenous Immunoglobulin Market to reach a value of US$ 15,789.1 Mn from US$ 9,787.6 Mn. The forecast period is set from 2018 and the market is expected to grow at a CAGR of 6.2%. All information related to the market is provided in the report, titled, “Intravenous Immunoglobulin Market Size, Share and Global Trend by Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Geography Forecast till 2025”.  The rising incidence of immunodeficiency diseases in both emerging and developed nations is propelling growth of the Intravenous Immunoglobulin market.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593

Increasing Adoption of Immunoglobulins to Help Asia Pacific Register Fastest Growth

According to the report, The Global Intravenous Immunoglobulin Market was dominated by North America with a market value of US$ 5,587.4 Mn in 2017. The region is likley to remain dominant through the forecast period as well due to the presence of first line treatment for critical immune disorders. Other factors boosting the market in the region are rising number of patients and efficient results of the intravenous immunoglobulin treatment.

On the other side, the market in Asia Pacific is anticipated to grpow at faster rate in the coming years on account of the rise in awareness about the treatment option avaiulable for immunologic deficiencies. In addition to this, the rise in adoption and expenditure of immunoglobulins in economies such as Japan, China,and Indiais anticipated to boost the market in the region.

Key Segmentation:

By Indication

  • Primary Immunodeficiency
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Guillain-Barré Syndrome (GBS)
  • Immune Thrombocytopenic Purpura (ITP)
  • Multifocal Motor Neuropathy (MMN)
  • Others

By Form

  • Liquid
  • Lyophilized

By End User

  • Hospitals
  • Clinics
  • Homecare

By Geography

  • North America (the U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America
  • Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/sample/intravenous-immunoglobulins-market-100593

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Intravenous Immunoglobulin market. Some of the companies operating the global Intravenous Immunoglobulin market are;

  • CSL Behring
  • Grifols, S.A.
  • Kedrion S.p.A
  • Octapharma
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products Holdings, Inc.
  • LFB SA and Shanghai RAAS Blood Products Co., Ltd.

Grifols, S.A., Leading Market with Better Product Offerings

Analysts at Fortune Business Insights foresees the Grifols, S.A., to emerge as the dominant player in the global market for intravenous immunoglobulin market. This is because this company was leading the market in the year 2017 as well, all because oftheir product offerings and the usual route of administration, whioch ultimately dominated a considerate proportion of share ion the market. Besides this, Grifols, S.A., accounts for largest revenues from well developed regions namely Europe and North America.

More Trending Topics From Fortune Business [email protected] 

Global Companion Animal Healthcare Market to Witness Remarkable Growth on Account of Improved Availability of Animal Healthcare Accessories

Medical Radiation Shielding Market 2019 Global Analysis, Opportunities and Forecast To 2026

Hematology Analyzers and Reagents Market: 2019 Potential Growth, Size, Share, Regional Analysis, Industry Outlook, Competitive Landscape, Trends

Categories
Press Release

Intravenous Immunoglobulin (IVIG) Market Threats In The Target Market, Market Study of Revenue Details

The Global Intravenous Immunoglobulins Market to gain from rapid technological advancements taking place in the market. Recently Fortune Business Insights has published a report, titled Intravenous Immunoglobulins Market Size, Share and Global Trend By Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Geography Forecast till 2025

Rapid adoption of digitalization among practitioners and patients is likely to fuel the demand in the global Intravenous Immunoglobulins market. Additionally, increasing per capita income and rising living standards is expected to drive the global Intravenous Immunoglobulins market during the forecast period 2018-2025.

However, high cost associated with the devices and lack of skilled professional to operate the system are a few factors that may hamper the growth in the global Intravenous Immunoglobulins market. 

As stated in the report North America holds a significant share in the market. The trend is unlikely to change and North America may continue holding its position. The growth witnessed is attributable to high presence of key developers in nations such as Canada and U.S.

The Asia Pacific Intravenous Immunoglobulins market is expected to expand at a promising CAGR during the forecast period. The constantly improving healthcare infrastructure in the region is expected to contribute to Asia Pacific market expansion.

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Intravenous Immunoglobulins market. Some of the companies operating the global Intravenous Immunoglobulins market are;

  • CSL Behring
  • Grifols, S.A.
  • Kedrion S.p.A
  • Octapharma
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products Holdings, Inc.
  • LFB SA and Shanghai RAAS Blood Products Co., Ltd.

TABLE OF CONTENT:

  1. Introduction

1.1.  Research Scope

1.2.  Market Segmentation

1.3.  Research Methodology

1.4.  Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1.  Market Drivers

3.2.  Market Restraints

3.3.  Market Opportunities

  1. Key Insights

4.1.  Pipeline Analysis

4.2.  Overview of Regulatory Scenario by Key Regions

4.3.  Key Industry Developments

4.4.  Number (Estimated) of Primary Immunodeficiency (PI) Patients by Key Countries

4.5.  Overview of Reimbursement Scenario

  1. Global Intravenous Immunoglobulins Market Analysis, Insights and Forecast, 2015-2025

5.1.  Key Findings /Summary

5.2.  Market Analysis, Insights and Forecast – By Indication

5.2.1.     Primary Immunodeficiency

5.2.2.     Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

5.2.3.     Guillain-Barré Syndrome (GBS)

5.2.4.     Immune Thrombocytopenic Purpura (ITP)

5.2.5.     Multifocal Motor Neuropathy (MMN)

5.2.6.     Others

5.3.  Market Analysis, Insights and Forecast – By Form

5.3.1.     Liquid

5.3.2.     Lyophilized

5.4.  Market Analysis, Insights and Forecast – By End User

5.4.1.     Hospitals

5.4.2.     Clinics

5.4.3.     Homecare

5.5.  Market Analysis, Insights and Forecast – By Region

5.5.1.     North America

5.5.2.     Europe

5.5.3.     Asia Pacific

5.5.4.     Latin America

5.5.5.     Middle East & Africa

More Trending Topics From Fortune Business [email protected]

Revenue Cycle Management Market 2019 Industry Size and Share Evolution to 2025 by Growth Insight, Trends, Key Development

Surgical Sutures Market Trends, Type, Segmentation, Analysis, Assessment, Development, Application

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Categories
Press Release

Intravenous Immunoglobulin (IVIG) Market Opportunities and Industry Segments Poised for Rapid Growth by 2025

The rapid adoption of digitalization among practitioners and patients is likely to fuel the demand in the global Intravenous Immunoglobulins market. Additionally, increasing per capita income and rising living standards is expected to drive the global Intravenous Immunoglobulins market during the forecast period 2018-2025.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593

However, high cost associated with the devices and lack of skilled professional to operate the system are a few factors that may hamper the growth in the global Intravenous Immunoglobulins market.

However, high cost associated with the devices and lack of skilled professional to operate the system are a few factors that may hamper the growth in the global Intravenous Immunoglobulins market. 

As stated in the report North America holds a significant share in the market. The trend is unlikely to change and North America may continue holding its position. The growth witnessed is attributable to high presence of key developers in nations such as Canada and U.S.

The Asia Pacific Intravenous Immunoglobulins market is expected to expand at a promising CAGR during the forecast period. The constantly improving healthcare infrastructure in the region is expected to contribute to Asia Pacific market expansion.

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/sample/intravenous-immunoglobulins-market-100593

TABLE OF CONTENT:

  1. Introduction

1.1.  Research Scope

1.2.  Market Segmentation

1.3.  Research Methodology

1.4.  Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1.  Market Drivers

3.2.  Market Restraints

3.3.  Market Opportunities

  1. Key Insights

4.1.  Pipeline Analysis

4.2.  Overview of Regulatory Scenario by Key Regions

4.3.  Key Industry Developments

4.4.  Number (Estimated) of Primary Immunodeficiency (PI) Patients byKey Countries

4.5.  Overview of Reimbursement Scenario

  1. Global Intravenous Immunoglobulins Market Analysis, Insights andForecast, 2015-2026

5.1.  Key Findings /Summary

5.2.  Market Analysis, Insights and Forecast – By Indication

5.2.1.     Primary Immunodeficiency

5.2.2.     Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

5.2.3.     Guillain-Barré Syndrome (GBS)

5.2.4.     Immune Thrombocytopenic Purpura (ITP)

5.2.5.     Multifocal Motor Neuropathy (MMN)

5.2.6.     Others

5.3.  Market Analysis, Insights and Forecast – By Form

5.3.1.     Liquid

5.3.2.     Lyophilized

5.4.  Market Analysis, Insights and Forecast – By End User

5.4.1.     Hospitals

5.4.2.     Clinics

5.4.3.     Homecare

5.5.  Market Analysis, Insights and Forecast – By Region

5.5.1.     North America

5.5.2.     Europe

5.5.3.     Asia Pacific

5.5.4.     Latin America

5.5.5.     Middle East & Africa

Key Segmentation:

By Form

  • Liquid
  • Lyophilized

By End User

  • Hospitals
  • Clinics
  • Homecare

Major Table of Content For Intravenous Immunoglobulins Market:

  1. Introduction
  2. Executive Summary
  3. Market Dynamics
  4. Key Insights
  5. Global Intravenous Immunoglobulins Market Analysis, Insights and Forecast

More Trending Topics From Fortune Business [email protected]

Contraceptive Devices Market 2019 Global Industry Size, Growth Factor Analysis Research Report 2025

Digital Blood Pressure Monitors Industry 2019 Global Market Growth, Size, Demand, Trends, Insights and Forecast 2025

Biopesticides Market 2019 Movements by Revenue Expectation, Growth Status, Trend Analysis, to 2025

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Categories
Press Release

Intravenous Immunoglobulins Market 2019 Opportunities, Analysis

The Global Intravenous Immunoglobulins Market to gain from rapid technological advancements taking place in the market. Recently Fortune Business Insights has published a report, titled Intravenous Immunoglobulins Market Size, Share and Global Trend By Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Geography Forecast till 2025

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593

Rapid adoption of digitalization among practitioners and patients is likely to fuel the demand in the global Intravenous Immunoglobulins market. Additionally, increasing per capita income and rising living standards is expected to drive the global Intravenous Immunoglobulins market during the forecast period 2018-2025.

TABLE OF CONTENT:

  1. Introduction

1.1.  Research Scope

1.2.  Market Segmentation

1.3.  Research Methodology

1.4.  Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1.  Market Drivers

3.2.  Market Restraints

3.3.  Market Opportunities

  1. Key Insights

4.1.  Pipeline Analysis

4.2.  Overview of Regulatory Scenario by Key Regions

4.3.  Key Industry Developments

4.4.  Number (Estimated) of Primary Immunodeficiency (PI) Patients byKey Countries

4.5.  Overview of Reimbursement Scenario

  1. Global Intravenous Immunoglobulins Market Analysis, Insights andForecast, 2015-2026

5.1.  Key Findings /Summary

5.2.  Market Analysis, Insights and Forecast – By Indication

5.2.1.     Primary Immunodeficiency

5.2.2.     Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

5.2.3.     Guillain-Barré Syndrome (GBS)

5.2.4.     Immune Thrombocytopenic Purpura (ITP)

5.2.5.     Multifocal Motor Neuropathy (MMN)

5.2.6.     Others

5.3.  Market Analysis, Insights and Forecast – By Form

5.3.1.     Liquid

5.3.2.     Lyophilized

5.4.  Market Analysis, Insights and Forecast – By End User

5.4.1.     Hospitals

5.4.2.     Clinics

5.4.3.     Homecare

5.5.  Market Analysis, Insights and Forecast – By Region

5.5.1.     North America

5.5.2.     Europe

5.5.3.     Asia Pacific

5.5.4.     Latin America

5.5.5.     Middle East & Africa

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Intravenous Immunoglobulins market. Some of the companies operating the global Intravenous Immunoglobulins market are;

  • CSL Behring
  • Grifols, S.A.
  • Kedrion S.p.A
  • Octapharma
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products Holdings, Inc.
  • LFB SA and Shanghai RAAS Blood Products Co., Ltd.

Major Table of Content For Intravenous Immunoglobulins Market:

  1. Introduction
  2. Executive Summary
  3. Market Dynamics
  4. Key Insights
  5. Global Intravenous Immunoglobulins Market Analysis, Insights and Forecast
  6. North America Intravenous Immunoglobulins Market Analysis, Insights and Forecast
  7. Europe Intravenous Immunoglobulins Market Analysis, Insights and Forecast
  8. Asia Pacific Intravenous Immunoglobulins Market Analysis, Insights and Forecast
  9. Middle East and Africa Intravenous Immunoglobulins Market Analysis, Insights and Forecast
  10. Latin America Intravenous Immunoglobulins Market Analysis, Insights and Forecast
  11. Competitive Landscape
  12. Company Profile
  13. Conclusion

Key Segmentation:

By Indication

  • Primary Immunodeficiency
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Guillain-Barré Syndrome (GBS)
  • Immune Thrombocytopenic Purpura (ITP)
  • Multifocal Motor Neuropathy (MMN)

By Form

  • Liquid
  • Lyophilized

By End User

  • Hospitals
  • Clinics
  • Homecare

However, high cost associated with the devices and lack of skilled professional to operate the system are a few factors that may hamper the growth in the global Intravenous Immunoglobulins market. 

The Asia Pacific Intravenous Immunoglobulins market is expected to expand at a promising CAGR during the forecast period. The constantly improving healthcare infrastructure in the region is expected to contribute to Asia Pacific market expansion.

As stated in the report North America holds a significant share in the market. The trend is unlikely to change and North America may continue holding its position. The growth witnessed is attributable to high presence of key developers in nations such as Canada and U.S.

More Trending Topics From Fortune Business [email protected]

Dental Implants Market 2019 Size, Revenue, Share and Global Trend By Material, Type, Design, End-user and Geography Forecast till 2026

Diabetes Drugs Market 2019 Size, Revenue, Share and Global Trend By Drug Class, Diabetes Type and Geography Forecast 2026

Veterinary Drugs Market by Size, Share, Industry Analysis, Development, Key Players, Competitive Landscape, Future Plans and Regional Trends Forecast 2025

Categories
Press Release

Intravenous Immunoglobulins Market: 2019 Regional Analysis, Industry Outlook, Potential Growth

The Global Intravenous Immunoglobulins Market to gain from rapid technological advancements taking place in the market. Recently Fortune Business Insights has published a report, titled Intravenous Immunoglobulins Market Size, Share and Global Trend By Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Geography Forecast till 2025

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593

Rapid adoption of digitalization among practitioners and patients is likely to fuel the demand in the global Intravenous Immunoglobulins market. Additionally, increasing per capita income and rising living standards is expected to drive the global Intravenous Immunoglobulins market during the forecast period 2018-2025.

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Intravenous Immunoglobulins market. Some of the companies operating the global Intravenous Immunoglobulins market are;

  • CSL Behring
  • Grifols, S.A.
  • Kedrion S.p.A
  • Octapharma
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products Holdings, Inc.
  • LFB SA and Shanghai RAAS Blood Products Co., Ltd.

Key Segmentation:

By Indication

  • Primary Immunodeficiency
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Guillain-Barré Syndrome (GBS)
  • Immune Thrombocytopenic Purpura (ITP)
  • Multifocal Motor Neuropathy (MMN)

By Form

  • Liquid
  • Lyophilized

By End User

  • Hospitals
  • Clinics
  • Homecare

Major Table of Content For Intravenous Immunoglobulins Market:

  1. Introduction
  2. Executive Summary
  3. Market Dynamics
  1. Key Insights
  2. Global Intravenous Immunoglobulins Market Analysis, Insights and Forecast
  3. North America Intravenous Immunoglobulins Market Analysis, Insights and Forecast

TABLE OF CONTENT:

  1. Introduction

1.1.  Research Scope

1.2.  Market Segmentation

1.3.  Research Methodology

1.4.  Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1.  Market Drivers

3.2.  Market Restraints

3.3.  Market Opportunities

  1. Key Insights

4.1.  Pipeline Analysis

4.2.  Overview of Regulatory Scenario by Key Regions

4.3.  Key Industry Developments

4.4.  Number (Estimated) of Primary Immunodeficiency (PI) Patients byKey Countries

4.5.  Overview of Reimbursement Scenario

  1. Global Intravenous Immunoglobulins Market Analysis, Insights andForecast, 2015-2026

5.1.  Key Findings /Summary

5.2.  Market Analysis, Insights and Forecast – By Indication

5.2.1.     Primary Immunodeficiency

5.2.2.     Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

5.2.3.     Guillain-Barré Syndrome (GBS)

5.2.4.     Immune Thrombocytopenic Purpura (ITP)

5.2.5.     Multifocal Motor Neuropathy (MMN)

5.2.6.     Others

More Trending Topics From Fortune Business [email protected]

Veterinary Scales Market Size 2019 Regional Trend | Forecast To 2026

Drugs Of Abuse Testing Market Perspective with Study of Revenue, Key Players to Steady Growth Forecast To 2019

Canned Mushroom Market Size 2019 Global Industry Analysis, Opportunities, Share, Top Manufacturers and Forecast to 2026

Categories
Press Release

The rapid increase in neurological disorders, increase in continuous and geriatric population increase in the number of patients are fueling the market growth.

The Global Intravenous Immunoglobulins Market to gain from rapid technological advancements taking place in the market. Recently Fortune Business Insights has published a report, titled Intravenous Immunoglobulins Market Size, Share and Global Trend By Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Geography Forecast till 2025

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593

Rapid adoption of digitalization among practitioners and patients is likely to fuel the demand in the global Intravenous Immunoglobulins market. Additionally, increasing per capita income and rising living standards is expected to drive the global Intravenous Immunoglobulins market during the forecast period 2018-2025.

TABLE OF CONTENT:

  1. Introduction

1.1.  Research Scope

1.2.  Market Segmentation

1.3.  Research Methodology

1.4.  Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1.  Market Drivers

3.2.  Market Restraints

3.3.  Market Opportunities

  1. Key Insights

4.1.  Pipeline Analysis

4.2.  Overview of Regulatory Scenario by Key Regions

4.3.  Key Industry Developments

4.4.  Number (Estimated) of Primary Immunodeficiency (PI) Patients byKey Countries

4.5.  Overview of Reimbursement Scenario

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/sample/intravenous-immunoglobulins-market-100593

However, high cost associated with the devices and lack of skilled professional to operate the system are a few factors that may hamper the growth in the global Intravenous Immunoglobulins market. 

As stated in the report North America holds a significant share in the market. The trend is unlikely to change and North America may continue holding its position. The growth witnessed is attributable to high presence of key developers in nations such as Canada and U.S.

More Trending Topics From Fortune Business [email protected]

Alpha-1 Antitrypsin Deficiency (AATD) Augmentation Therapy Market to Grow at 5.9% CAGR to Reach US$ 1959.8 Mn by 2026

Diabetes Monitoring Devices Market 2019 Segmentation, Size, Share, Trend, Global Industry Growth Analysis, Future Demand by Forecast to 2026

Biopesticides Market 2019 Movements by Revenue Expectation, Growth Status, Trend Analysis, to 2025